Lecture1 6/18 PRESCRIPTION REVIEW

53
DISPENSING AND MEDICATION DISPENSING AND MEDICATION COUNSELING COUNSELING

Transcript of Lecture1 6/18 PRESCRIPTION REVIEW

Page 1: Lecture1 6/18 PRESCRIPTION REVIEW

DISPENSING AND MEDICATION DISPENSING AND MEDICATION COUNSELINGCOUNSELING

Page 2: Lecture1 6/18 PRESCRIPTION REVIEW

DEFINE: PRESCRIPTION

Page 3: Lecture1 6/18 PRESCRIPTION REVIEW

PRESCRIPTION

• A written order by the doctor to a pharmacist specifying the medications to be dispensed to a specific patient and usually accompanied by directions for use and administration.

• "pre"- before• "script" - written

Page 4: Lecture1 6/18 PRESCRIPTION REVIEW

Enumerate the parts of a prescription:

Page 5: Lecture1 6/18 PRESCRIPTION REVIEW

parts of a prescription

• prescriber's information• patient's information• date• superscription• inscription• subscription• transcription• special labeling/other instruction

such as refill number

Page 6: Lecture1 6/18 PRESCRIPTION REVIEW

sample prescription

Page 7: Lecture1 6/18 PRESCRIPTION REVIEW

Three Types of Unethical Prescription.

Page 8: Lecture1 6/18 PRESCRIPTION REVIEW

Describe Violative Rx.

Page 9: Lecture1 6/18 PRESCRIPTION REVIEW

types of unethical prescription

• violative prescription

» where generic name is not written» where the generic name is not legible

while the brand name is legibly written» when the brand name is indicated with

instruction such as "no substitution" is written which hinder proper generic dispensing

Page 10: Lecture1 6/18 PRESCRIPTION REVIEW

violative prescription

1

2

3

Page 11: Lecture1 6/18 PRESCRIPTION REVIEW

Describe Erroneous Rx.

Page 12: Lecture1 6/18 PRESCRIPTION REVIEW

types of unethical prescription

• erroneous prescription

» where the brand name precedes the generic name

» where the generic name is the one in the parenthesis

» where the brand name is not in parenthesis

» where more than one product is prescribed on one prescription form

Page 13: Lecture1 6/18 PRESCRIPTION REVIEW

erroneous prescription

Page 14: Lecture1 6/18 PRESCRIPTION REVIEW

Describe Impossible Rx.

Page 15: Lecture1 6/18 PRESCRIPTION REVIEW

types of unethical prescription

• impossible prescription

» where only the generic name is written but is not legible

» where the generic name does not correspond to the brand name

» where both the generic name and the brand name are not legibly written

» when the drug product prescribed is not registered with FDA

Page 16: Lecture1 6/18 PRESCRIPTION REVIEW

impossible prescription

» BFAD Advisory No. 02-02 || MISOPROSTOL (CYTOTE): Unregistered Drug Product

Page 17: Lecture1 6/18 PRESCRIPTION REVIEW

What to do with this kinds of Rx?

Page 18: Lecture1 6/18 PRESCRIPTION REVIEW

what to do if you receive such type of prescription

• erroneous prescription» shall be filled» such prescription shall be kept and

reported to the nearest FDA office for appropriate action

• violative and impossible prescriptions

» shall not be filled » pharmacist shall advise the prescriber of

the problem and instruct the customer to get te proper prescription

» such prescription must be kept and reported to the nearest FDA office for appropriate action

Page 19: Lecture1 6/18 PRESCRIPTION REVIEW

What to do upon receipt of Rx?

Page 20: Lecture1 6/18 PRESCRIPTION REVIEW

Proper handling of Prescription

1. Receiving the prescription2. Reading & checking the prescription3. Numbering & dating4. Labeling5. Preparing the prescription6. Packaging7. Rechecking8. Delivery & counseling9.Recording & filing10.Pricing the prescription

Page 21: Lecture1 6/18 PRESCRIPTION REVIEW

Prescription then what?What to check out for?

Page 22: Lecture1 6/18 PRESCRIPTION REVIEW

Read and Check Rx for:

I - InteractionD- DoseE- Evidence of harm/ benefitA- AppropriateL- Legal and completeC- Cost effectiveA- Acceptable to the pxS-E-

Page 23: Lecture1 6/18 PRESCRIPTION REVIEW

Prescription vs non-rx?

Page 24: Lecture1 6/18 PRESCRIPTION REVIEW

Broad classification of medication

• OTC / Non-prescription Drug

» drugs that do not require a doctor's prescription

» can be bought off-the-shelf in stores» regulated by FDA through the OTC drug

monograph

Page 25: Lecture1 6/18 PRESCRIPTION REVIEW

Broad classification of medication

• Prescription / Legend Drug

» prescribed by a doctor» can only be bough at a pharmacy» prescribed for and intended to be used by

one patient» regulated by FDA through the New Drug

Application process

Page 26: Lecture1 6/18 PRESCRIPTION REVIEW

What is a narcotic drug?

Page 27: Lecture1 6/18 PRESCRIPTION REVIEW

NARCOTICS

• a drug that produce analgesia, narcosis, and addiction

• narcotic prescription(should be in triplicate)

» one copy for the medical practitioner» one copy for the pharmacy/pharmacist» one copy for the patient

Page 28: Lecture1 6/18 PRESCRIPTION REVIEW

Controlled (Regulated) drug substance

• Any drug or therapeutic agent–commonly understood to include narcotics, with a potential for abuse or addiction, which is held under strict governmental control and are placed in specific schedules.

• Require specialized prescription blanks.

Page 29: Lecture1 6/18 PRESCRIPTION REVIEW

FDA Controlled Substances

• Drugs, substances, and certain chemicals used to make drugs are classified into five (5) distinct categories or schedules depending upon the drug’s acceptable medical use and the drug’s abuse or dependency potential.

Page 30: Lecture1 6/18 PRESCRIPTION REVIEW

FDA Controlled Substances

Schedule I

• drugs with no currently accepted medical use

• high potential for abuse• most dangerous drugs of

all the drug schedules with potentially severe psychological or physical dependence.

No prescriptions

may be written for Schedule I

substances, and they are not readily

available for clinical use.

Page 31: Lecture1 6/18 PRESCRIPTION REVIEW

Give an example of drugs under Schedule I.

Page 32: Lecture1 6/18 PRESCRIPTION REVIEW

Schedule I• Gamma-Hydroxybutyric Acid (GHB)• 12-Methoxyibogamine (Ibogaine)• Marijuana (cannabis)• Methaqualone• Diacetylmorphine (Heroin)• Pholcodine• methylenedioxymethamphetamine (MDMA) or (ecstasy)• Mescaline (Peyote)• alpha-methyltryptamine (AMT)• Bufotenin• dextorphan (DXO)• Benzylpiperazine (BZP)• lysergic acid diethylamide (LSD)

Page 33: Lecture1 6/18 PRESCRIPTION REVIEW

FDA Controlled Substances

Schedule II• drugs with a high

potential for abuse but less abuse potential than S- I drugs

• with use potentially leading to severe psychological or physical dependence

Substance II drugs may not be

dispensed without written prescription

from a doctor. Prescriptions of

substance II drugs are in a "closed

system". This means, the prescription may not be refilled, unless medically required.

Page 34: Lecture1 6/18 PRESCRIPTION REVIEW

Give an example of drugs under Schedule II.

Page 35: Lecture1 6/18 PRESCRIPTION REVIEW

Schedule II• Methylphenidate (Ritalin)• Meperidine (Demerol)• Cocaine• Opium• Methadone (Dolophine)• Oxycodone (OxyContin)• Fentanyl (Sublimate)• Morphine• Mixed Amphetamine Salts (Adderall)• Lisdexamfetamine (Vyvanse)• Dextroamphetamine (Dexedrine)• Methamphetamine (Desoxyn)• Hydrocodone (Vicodin)• Hydromorphone (Dilaudid)• Secobarbital (Seconal)• Pethidine• Nabilone (Cesamet)• Tapentadol

Page 36: Lecture1 6/18 PRESCRIPTION REVIEW

FDA Controlled Substances

Schedule III

• drugs with a moderate to low potential for physical and psychological dependence.

• with a currently accepted medical use in treatment

Schedule III drugs may not be used without prescription from

a doctor. Prescriptions may not be refilled after six months of the date they were issued

for use.

Page 37: Lecture1 6/18 PRESCRIPTION REVIEW

Give an example of drugs under Schedule III.

Page 38: Lecture1 6/18 PRESCRIPTION REVIEW

Schedule III• Anabolic Steroids• Buprenorphine• Amphetamine• Dihydrocodeine• Ketamine• Xyrem• Hydrocodone/Codeine• Marinol• Lysergic Acid Amide (LSA)• Paregoric• Barbiturates (Short acting)

Page 39: Lecture1 6/18 PRESCRIPTION REVIEW

FDA controlled substances

Schedule IV

• drugs with a low potential for abuse and low risk of physical or psychological dependence.

• with a currently accepted medical use in treatment.

Prescriptions for Schedule IV

drugs may be refilled up to five times within six

months.

Page 40: Lecture1 6/18 PRESCRIPTION REVIEW

Give an example of drugs under Schedule IV.

Page 41: Lecture1 6/18 PRESCRIPTION REVIEW

Schedule IV• Alprazolam (Xanax)• Diazepam (Valium)• Lorazepam (Ativan)• Temazepam (Restoril)• Barbiturates (Long acting)• Modafinil (Provigil)• Dextropropoxyphene (Darvon)• Carisoprodol (Soma)• Propoxyphene (Darvon)• Zolpidem (Ambien)• Tramadol• Difenoxin

Page 42: Lecture1 6/18 PRESCRIPTION REVIEW

FDA Controlled Substances

Schedule V

• drugs with lower potential for abuse than S- IV and consist of preparations containing limited quantities of certain narcotics.

• Abuse of the drug may lead to limited physical dependence or psychological dependence.

• generally used for antidiarrheal, antitussive, and analgesic purposes.

No drug found in schedule V may be dispensed or distributed for anything other than medicinal

use.

Page 43: Lecture1 6/18 PRESCRIPTION REVIEW

Give an example of drugs under Schedule V.

Page 44: Lecture1 6/18 PRESCRIPTION REVIEW

Schedule V• cough preparations with less than 200 mg of

codeine (Robitussin AC)• Lomotil• Motofen• Lyrica• Parepectolin

Page 45: Lecture1 6/18 PRESCRIPTION REVIEW

Give one tip to avoid ambiguity in prescription.

Page 46: Lecture1 6/18 PRESCRIPTION REVIEW

Conventions in avoiding ambiguity

1. Careful use of decimal point2. Directions in full english3. Direction should be specific4. Use of permanent ink5. Avoid units such as tsp/ tbsp6. Writing out numbers as words7. Use of apothecary units8. Use of degree symbol

Page 47: Lecture1 6/18 PRESCRIPTION REVIEW

How can we classify if a drug is considered safe for Pregnant women?

Page 48: Lecture1 6/18 PRESCRIPTION REVIEW

FDA Pregnancy Categories

• The FDA has established five categories to indicate the potential of a drug to cause birth defects if used during pregnancy. The categories are determined by the reliability of documentation and the risk to benefit ratio.

Page 49: Lecture1 6/18 PRESCRIPTION REVIEW

FDA Pregnancy Categories

• Category A• Adequate and well-controlled studies have

failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).

• levothyroxine• folic acid• magnesium sulfate• liothyronine

Page 50: Lecture1 6/18 PRESCRIPTION REVIEW

FDA Pregnancy Categories

• Category B• Animal reproduction studies have failed to

demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.

• metformin• hydrochlorothiazide• cyclobenzaprine• amoxicillin• pantoprazole

Page 51: Lecture1 6/18 PRESCRIPTION REVIEW

FDA Pregnancy Categories

• Category C• Animal reproduction studies have shown an

adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

• tramadol• gabapentin• amlodipine• trazodone• prednisone

Page 52: Lecture1 6/18 PRESCRIPTION REVIEW

FDA Pregnancy Categories

• Category D• There is positive evidence of human fetal risk

based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

• lisinopril• alprazolam• losartan• clonazepam• lorazepam

Page 53: Lecture1 6/18 PRESCRIPTION REVIEW

FDA Pregnancy Categories

• Category X• Studies in animals or humans have

demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits.

• atorvastatin• simvastatin• warfarin• methotrexate• finasteride